查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1874587

全球细胞分散市场

Cell Dissociation
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球细胞分离市场预计2030年将达到9.604亿美元

全球细胞分离市场规模在2024年估计为4.959亿美元，预计到2030年将达到9.604亿美元，在分析期（2024-2030年）内复合年增长率（CAGR）为11.6%。本报告分析的细分市场之一—酵素分离产品，预计将以12.6%的复合年增长率成长，并在分析期间结束时达到5.069亿美元。非酵素分离产品细分市场预计在分析期间内将以11.1%的复合年增长率成长。

美国市场规模估计为1.367亿美元，而中国市场预计将以11.1%的复合年增长率成长。

预计到2024年，美国细胞分离市场规模将达到1.367亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到1.487亿美元，在2024年至2030年的分析期内，复合年增长率（CAGR）将达到11.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期内，这两个市场的复合年增长率将分别达到10.3%和9.6%。在欧洲，德国的复合年增长率预计将达到约8.3%。

全球细胞分离市场—关键趋势与驱动因素概述

细胞分散技术如何影响现代生物医学研究？

细胞分散是生物医学研究和治疗开发中的关键步骤，它使研究人员能够将贴壁细胞从培养环境中分离出来，或将组织分散成单一细胞。这项技术对于多种应用至关重要，包括细胞培养、干细胞研究、流式细胞技术和单细胞定序。科学家可以使用胰蛋白酶和胶原蛋白酶等酵素或非酵素溶液，在不损害细胞活力或功能的情况下，温和地将细胞从基材中释放出来。对于后续培养、基于细胞的检测以及涉及细胞重编程的研究而言，获得具有活性和功能的细胞至关重要。细胞分散广泛应用于癌症研究，其中肿瘤组织必须分散成单一细胞才能进行分子分析和药物筛检。它在组织工程和再生医学中也至关重要，在这些领域中，需要分离特定类型的细胞来开发支架和人工组织。技术和试剂的进步使细胞分散更加高效，从而在最大限度地减少细胞损伤的同时，提高了活细胞的产量。这个过程的重要性涵盖了广泛的生物学研究，使其成为基础科学和应用医学研究的基本工具。

为什么细胞分散对于单细胞分析和治疗方法开发至关重要？

细胞解离在单细胞分析中发挥至关重要的作用。单细胞分析是一个新兴的生物医学研究领域，旨在揭示组织内的细胞多样性。诸如RNA定序和蛋白质组学等单细胞技术需要将组织分解成单一细胞，以分析特定细胞群内细胞的遗传和表型变异。这在癌症研究中尤其重要，因为了解肿瘤多样性可以为疾病进展和治疗抗药性提供重要的见解。在免疫学中，细胞分散可以分离特定的免疫细胞群，用于深入的功能研究和药物测试。此外，在细胞治疗方法（包括CAR-T细胞疗法和干细胞移植）的开发中，分散过程可确保从组织切片检查或培养系统中获得足够数量的活细胞用于治疗。分离通讯协定必须能够维持细胞功能，这一点至关重要，因为在此过程中对细胞膜或受体的损伤会影响后续分析和治疗效果。随着单细胞生物学领域的不断发展，对优化细胞分离技术的需求预计将会增长，这凸显了能够保持细胞完整性的精确而温和的分离技术的重要性。

科技进步如何提高细胞解离的效率？

技术进步显着提高了细胞解离方法的效率和可靠性，推动了研发和临床应用领域的创新。新型酵素组合药物和试剂的开发，最大限度地提高了细胞活力，同时最大限度地缩短了细胞分离所需的时间。例如，一些最新的酵素混合物能够更有效地解离那些难以用传统胰蛋白酶方法解离的组织，例如纤维化组织和富含胶原蛋白的样本。除了酵素法之外，非酵素解离方法也日益普及。这些方法能够在解离细胞的同时，最大限度地减少对细胞表面蛋白的影响，使其成为流式细胞技术和受体分析等敏感应用的理想选择。自动化和高通量系统也改善了细胞解离，使得同时处理多个样本并提高精确度成为可能。微流体技术和机械解离装置为酵素法提供了替代方案，降低了酵素损伤的风险，并能够解离更复杂的组织，例如脑组织和肝臟样本。这些创新不仅提高了分离细胞的品质和数量，而且扩大了可有效研究的组织和应用范围，为基于细胞的研究和临床治疗开闢了新的可能性。

哪些因素正在推动细胞分散市场的成长？

细胞分离市场的成长受多种因素驱动，包括生物技术的进步、个人化医疗的兴起以及对细胞疗法日益增长的需求。其中一个关键驱动因素是药物发现和开发中对高品质单细胞的需求不断增长。製药公司和研究机构依赖分离的细胞进行新药筛检，尤其是肿瘤学和免疫疗法等领域。再生医学中干细胞研究的扩展也推动了对能够维持干细胞活力和分化潜能的优化细胞分离技术的需求。技术进步，例如更高效的酶促和非酶分离试剂的开发，正在推动实验室和临床环境中的应用，使该过程更加可靠和扩充性。基因组学和蛋白​​质组学中向单细胞分析的转变也是一个主要驱动因素，分离是分离单一细胞进行深入分子研究的关键步骤。消费行为，例如医疗费用支出的增加以及慢性病和癌症盛行率的上升，进一步推动了市场成长。此外，细胞分离技术在新兴领域（例如3D生物列印和组织工程）的日益普及，为建构复杂的组织结构提供了对细胞群的精确控制，从而创造了新的市场扩张机会。预计这些趋势将在未来几年内持续推动细胞分离市场的快速成长。

部分：

产品类型（酵素分离产品、非酵素分离产品、设备和配件）、组织（结缔组织、上皮组织、其他组织）、最终用途（製药和生物技术公司、研究和学术机构、其他最终用途）

受访公司范例

  • American Type Culture Collection（ATCC）
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HiMedia Laboratories
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • PAN-Biotech GmbH
  • StemCell Technologies Inc.
  • Thermo Fisher Scientific, Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，改变您分析市场和竞争情报的方式。

Global Industry Analysts 并没有依赖通用的 LLM 或查询产业专用的SLM，而是建立了一个由世界各地领域专家精心整理的内容库，包括视讯转录、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

我们最新发布的报告纳入了关税对区域市场的影响，正如全球产业分析师预测的那样，关税将改变企业的竞争地位，而企业的竞争地位将取决于其总部所在地、製造地以及进出口（成品和OEM产品）。这种复杂多变的市场现实将透过微观和宏观市场动态影响竞争对手，包括销货成本增加、盈利下降以及供应链重组。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP10940

Global Cell Dissociation Market to Reach US$960.4 Million by 2030

The global market for Cell Dissociation estimated at US$495.9 Million in the year 2024, is expected to reach US$960.4 Million by 2030, growing at a CAGR of 11.6% over the analysis period 2024-2030. Enzymatic Dissociation Products, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$506.9 Million by the end of the analysis period. Growth in the Non-enzymatic Dissociation Products segment is estimated at 11.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$136.7 Million While China is Forecast to Grow at 11.1% CAGR

The Cell Dissociation market in the U.S. is estimated at US$136.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$148.7 Million by the year 2030 trailing a CAGR of 11.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.3% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Cell Dissociation Market - Key Trends and Drivers Summarized

How Is Cell Dissociation Shaping Modern Biomedical Research?

Cell dissociation is a critical process in biomedical research and therapeutic development, enabling researchers to separate adherent cells from their culture environment or dissociate tissues into single cells. This technique is essential for various applications, including cell culture, stem cell research, flow cytometry, and single-cell sequencing. By using enzymes such as trypsin, collagenase, or non-enzymatic solutions, scientists can gently release cells from their substrates without compromising cell viability or function. The ability to obtain viable, functional cells is paramount for studies that involve subsequent culturing, cell-based assays, or cellular reprogramming. Cell dissociation is widely used in cancer research, where tumor tissues must be dissociated into individual cells for molecular analysis or drug screening. It is also crucial in tissue engineering and regenerative medicine, where the isolation of specific cell types is required for developing scaffolds and artificial tissues. With advancements in techniques and reagents, cell dissociation has become more efficient, enabling researchers to achieve higher yields of viable cells while minimizing cell damage. The significance of this process extends across a broad range of biological research fields, making it a fundamental tool in both basic science and applied medical research.

Why Is Cell Dissociation Essential for Single-Cell Analysis and Therapeutics?

Cell dissociation plays a pivotal role in single-cell analysis, a rapidly growing field in biomedical research that seeks to understand cellular heterogeneity within tissues. Single-cell technologies, such as RNA sequencing and proteomics, require the dissociation of tissues into individual cells to analyze the genetic and phenotypic diversity of cells in a given population. This is particularly important in cancer research, where understanding tumor heterogeneity can reveal critical insights into disease progression and treatment resistance. In immunology, cell dissociation enables the isolation of specific immune cell populations for in-depth functional studies and drug testing. Furthermore, in the development of cell-based therapeutics, including CAR-T cell therapy and stem cell transplants, the dissociation process ensures that enough viable cells are obtained from tissue biopsies or culture systems for therapeutic use. Ensuring that dissociation protocols preserve cell functionality is essential, as any damage to cell membranes or receptors during the process could affect downstream analysis or therapeutic efficacy. As the field of single-cell biology continues to expand, the demand for optimized cell dissociation techniques will only increase, emphasizing the importance of precise and gentle dissociation methods to preserve cell integrity.

How Are Technological Advancements Enhancing the Efficiency of Cell Dissociation?

Technological advancements have significantly improved the efficiency and reliability of cell dissociation methods, driving innovation in both research and clinical applications. New enzymatic formulations and reagents have been developed to minimize the time required for cell detachment while maximizing cell viability. For example, some of the newer enzyme blends can dissociate more resistant tissues, such as fibrotic or heavily collagenous samples, more effectively than traditional methods like trypsinization. In addition to enzymes, non-enzymatic solutions have gained traction for their ability to dissociate cells with reduced impact on surface proteins, making them ideal for sensitive applications like flow cytometry and receptor analysis. Automation and high-throughput systems have also enhanced cell dissociation, allowing laboratories to process multiple samples simultaneously and with greater precision. Microfluidics and mechanical dissociation devices provide alternative methods to enzymatic approaches, reducing the risk of enzyme-induced damage and enabling the dissociation of more complex tissues, such as brain or liver samples. These innovations not only improve the quality and quantity of dissociated cells but also expand the range of tissues and applications that can be effectively studied, pushing the boundaries of cell-based research and clinical therapeutics.

What Is Driving the Growth in the Cell Dissociation Market?

The growth in the cell dissociation market is driven by several factors, including advancements in biotechnology, the rise of personalized medicine, and increasing demand for cell-based therapies. One of the key drivers is the growing need for high-quality single cells in drug discovery and development. Pharmaceutical companies and research institutions rely on dissociated cells to screen for new drugs, particularly in areas like oncology and immunotherapy. The expansion of stem cell research, especially in regenerative medicine, is also fueling demand for optimized cell dissociation techniques that can preserve stem cell viability and differentiation potential. Technological advancements, such as the development of more efficient enzymatic and non-enzymatic dissociation reagents, are driving adoption in laboratories and clinics, making the process more reliable and scalable. The shift toward single-cell analysis in genomics and proteomics is another major factor, as dissociation is a critical step in isolating individual cells for detailed molecular studies. Consumer behavior in the form of increased healthcare spending, along with the rising prevalence of chronic diseases and cancer, is further propelling market growth. Additionally, the increasing use of cell dissociation in emerging applications such as 3D bioprinting and tissue engineering presents new opportunities for market expansion, as these fields require precise control over cell populations for the creation of complex tissue structures. Together, these trends are expected to sustain the rapid growth of the cell dissociation market in the coming years.

SCOPE OF STUDY:

The report analyzes the Cell Dissociation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, Instruments & Accessories); Tissue (Connective Tissue, Epithelial Tissue, Other Tissues); End-Use (Pharma & Biotech Companies, Research & Academic Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • American Type Culture Collection (ATCC)
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HiMedia Laboratories
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • PAN-Biotech GmbH
  • StemCell Technologies Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Cell Dissociation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise of Single-Cell Analysis Expands Addressable Market Opportunity
    • Increasing Use of Cell-Based Assays in Drug Discovery Spurs Market Growth
    • Advanced Enzymatic Dissociation Technologies Drive Adoption in Cancer Research
    • High-Throughput Screening Propels Demand for Automated Cell Dissociation Systems
    • Growing Application of 3D Cell Cultures Generates New Market Opportunities
    • Stem Cell Research and Therapy Drive Adoption of Optimized Cell Dissociation Protocols
    • Advancements in Microfluidic Technology Propel Innovation in Cell Isolation and Dissociation
    • Increased Focus on Immunotherapy Expands Demand for Gentle Cell Dissociation Solutions
    • Growth of Regenerative Medicine Sustains Demand for Customized Dissociation Technologies
    • Rise of Biopharmaceuticals Drives Demand for Scalable Cell Dissociation Processes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Dissociation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Dissociation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Cell Dissociation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Enzymatic Dissociation Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Enzymatic Dissociation Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Non-enzymatic Dissociation Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Non-enzymatic Dissociation Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Instruments & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Connective Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Connective Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Epithelial Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Epithelial Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Tissues by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Other Tissues by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • JAPAN
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • CHINA
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • EUROPE
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Cell Dissociation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Cell Dissociation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • FRANCE
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • GERMANY
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • UNITED KINGDOM
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2025 & 2030

IV. COMPETITION